Prognostic indices for bladder cancer: An analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy

https://doi.org/10.1016/S0167-8140(86)80060-3Get rights and content

Summary

A group of 889 patients who completed radical X-ray therapy for transitional cell carcinoma of the bladder during a 12 year period were analysed by a multivariate technique. The patient's age, tumour category, tumour size and haemoglobin level were shown to be independent prognostic covariates. A prognostic index was derived and four prognostic subgroups were identified. The prognostic index could divide patients within each T category into those with good, moderate, fair or poor prognosis. The 5 year actuarial survival rate for patients in the poor prognosis group was 5.8% compared to 69.8% for patients in the good prognosis group. Durable local tumour control after radical radiotherapy was also analysed by a multivariate technique. Tumour category, grade, haemoglobin and urea level were found to be significant covariates. A tumour control index was derived and two groups were identified corresponding to a high probability of lasting local control after radical radiotherapy (47.8% of patients) or a low probability of control (52.2%).

References (20)

There are more references available in the full text version of this article.

Cited by (46)

  • Radiochemotherapy for Bladder Cancer

    2009, Clinical Oncology
    Citation Excerpt :

    With standard fractionation (1.8–2 Gy/fraction), the total radiation dose is typically in the range of 45–50 Gy to treat the pelvic lymph nodes and between 55 and 70 Gy to the bladder. At least four retrospective analyses have suggested improved local control with doses greater than 55–60 Gy [23–26]; however, others have found no evidence to support such a relationship [27,28]. Phase III randomised trials comparing different conventionally fractionated dose schedules have never been undertaken.

  • Long-term outcome of radiation-based conservation therapy for invasive bladder cancer

    2007, Urologic Oncology: Seminars and Original Investigations
  • Anaemia is Associated with Poor Overall Survival but not with Inferior Local Control in Patients with Muscle Invasive Bladder Carcinoma Treated by Radical External Beam Radiotherapy. A Retrospective Study

    2006, Clinical Oncology
    Citation Excerpt :

    A number of independent studies have previously identified prognostic factors for outcome after radical radiotherapy for muscle invasive bladder cancer. These include tumour grade, stage, presence of CIS, multiple tumours, macroscopic tumour appearance, presence of ureteric obstruction, clinical response at the first check cystoscopy after radiotherapy, age and performance status [14,15,17,18,24–27]. In this retrospective study, 52% of patients were anaemic before starting radiotherapy.

  • Epidermal Growth Factor Receptor Status Predicts Local Response to Radical Radiotherapy in Muscle-invasive Bladder Cancer

    2006, Clinical Oncology
    Citation Excerpt :

    Similar analyses have been carried out regarding factors that can independently predict local tumour control after radiotherapy (as opposed to overall survival). Independent predictive factors determined by multiple logistic regression vary from study to study, but in general, increasing age, increasing tumour stage and grade, low haemoglobin levels and high urea levels have been consistently associated with poor local control after radical radiotherapy [3,6,7]. The benefit of predicting local control is that it has consistently been shown to be associated with subsequent improved overall survival [3,7,8].

  • Pre-treatment Haemoglobin Levels and the Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer

    2006, Clinical Oncology
    Citation Excerpt :

    A low pre-treatment haemoglobin level has been shown to negatively influence outcome in the management of a number of cancers, including those of the cervix [1], bladder [2] and head and neck [3,4].

  • Radiation therapy for muscle-invasive bladder cancer: Treatment planning and delivery

    2005, Clinical Oncology
    Citation Excerpt :

    Radiation organ sparing therapy is limited to patients with disease confined to the pelvis with good bladder function. Positive predictors of outcome include patients of younger age, with lower tumour stage, absence of pelvic nodal disease, normal renal function and absence of hydronephrosis, normal haemoglobin and a complete trans-urethral resection [3–6]. Tumour staging with magnetic resonance or cross-sectional computed tomography (CT) is mandatory to ensure appropriate patient selection and improve treatment outcomes.

View all citing articles on Scopus
View full text